Trials / Recruiting
RecruitingNCT05309343
Cohort Study on Treatment of Cardiovascular Diseases With Traditional Chinese Medicine
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 20,000 (estimated)
- Sponsor
- Tianjin University of Traditional Chinese Medicine · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
This is a cohort study performed in patients with cardiovascular diaeases who were treated with oral Chinese medicine and Western medicine. Collect indicators such as the incidence of cardiovascular events, all due to readmission, all due to death. To hospital using clinical samples to detect genomics, proteomics, metabolomics, intestinal flora and sclerotia.To explore the clinical efficacy of Chinese patent medicine in the treatment of cardiovascular diseases, and provide reliable data support for its clinical application.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Chinese patent medicine | Shexiang Baoxin Pill, Tongxinluo Capsule, Tongmai Yangxin Pill, Xuefu Zhuyu Capsule, Qishen Yiqi Dropping Pill, etc. |
Timeline
- Start date
- 2021-11-01
- Primary completion
- 2024-04-01
- Completion
- 2031-11-01
- First posted
- 2022-04-04
- Last updated
- 2022-04-04
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05309343. Inclusion in this directory is not an endorsement.